Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]

J. George, Woolf Sh, G. Raskob et al. · Blood · 1996 · 1.4K citations

Medicine, Hematology, Internal Medicine +9

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]

JN George, Woolf Sh, Raskob Ge et al. · Blood · 1996 · 1.2K citations · Full text

Medicine, Hematology, Internal Medicine +9

UK population norms for EQ-5D

Paul Kind, Geoffrey Hardman, Susan Macran · RePEc: Research Papers in Economics · 1999 · 442 citations

Pharmacy, Health Policy, Health Assessment +16

The Bleeding Risk and Natural History of Idiopathic Thrombocytopenic Purpura in Patients With Persistent Low Platelet Counts

Yaël C. Cohen, Benjamin Djulbegović, Orna Shamai‐Lubovitz et al. · Archives of Internal Medicine · 2000 · 426 citations

Medicine, Hematology, Clinical Epidemiology +9

Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease

Andrew Briggs, Ron Goeree, G. Blackhouse et al. · Medical Decision Making · 2002 · 361 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17